CAGRILINTIDE 5 MG

Cagrilintide is a next-level amylin analog used in research on aggressive appetite control and weight management. It’s often explored alongside incretin therapies to understand how stacking gut-brain signals can reshape body weight and metabolic health.

How It Works
Cagrilintide acts on amylin and calcitonin receptors in the brainstem and hypothalamus—key hubs for satiety and meal termination. By enhancing post-prandial satiety and slowing gastric emptying, it reduces food intake and supports negative energy balance. When combined experimentally with GLP-1 agonists, it offers a multi-pathway attack on obesity.

Regulatory & Research Note
Cagrilintide is an investigational agent, not approved by the FDA for general clinical use. This product is supplied for research use only and is not for human administration.